Reply: Iatrogenic breaching of the junctional zone: the unintended path to placenta accreta spectrum?

The authors have no acknowledgements to declare.

Contributors: Surgical and Medical Practices: E.G., P.T., H.V.K., S.K., I.A., A.S., R.C., S.G., Concept: E.G., R.C., S.G., Design: R.C., E.G., S.G., P.T., Data Collection or Processing: E.G., R.C., S.G., P.T., I.A., A.S., H.V.K., Analysis or Interpretation: E.G., R.C., S.G., P.T., Literature Search: E.G., P.T., Writing: E.G., P.T., R.C., S.G. Funding: The authors declared that this study received no financial support. Competing interests: No conflict of interest was declared by the authors. Ethical approval: This study was conducted in accordance with the ethical standards outlined in the Helsinki Declaration and its later amendments and was approved by the Hospital Ethics Committee of CHU Brugmann (le Comité d’Ethique Hospitalier du CHU Brugmann), approval number CE 2024/111, date: 13.08.2024. Informed consent: Informed consent was obtained from all individual participants included in this study. Data sharing: All data is available to be shared upon request to the corresponding author. Transparency: The authors affirm that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.